We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

QUIDEL

Develops, manufactures and markets rapid diagnostic tests at the point-ofcare (POC) that focus on infectious diseases... read more Featured Products: More products

Download Mobile App





QuidelOrtho Demonstrates Advanced Diagnostic Laboratory Solutions across Healthcare Continuum

By LabMedica International staff writers
Posted on 29 Jul 2024

At the Association for Diagnostics & Laboratory Medicine (ADLM) 2024 conference, QuidelOrtho Corporation (San Diego, CA, USA) is presenting its flexible and reliable solutions that deliver quality diagnostic results across the entire healthcare continuum - from home to hospital, lab to clinic. More...

QuidelOrtho is providing onsite demonstrations of its diverse product lines including Vitros automation solutions which can reduce manual steps, increase efficiency, and free up lab staff to focus on the delivery of quality results while reducing operational costs. QuidelOrtho is also demonstrating the Vitros XT 7600 system which offers a full clinical chemistry and immunoassay menu in one easy-to-use system that delivers industry-leading uptime. The system’s built-in technologies improve efficiency and quality, allowing for scalable automation solutions that streamline workflow. Visitors to QuidelOrtho’s booth at ADLM 2024 can experience the Vitros XT 3400 Chemistry System which is powered by intelligent technologies and digital imaging technology to help labs meet routine testing needs, with proven high-quality results and system reliability in a small footprint. QuidelOrtho is also demonstrating the Ortho Vision Max Swift analyzer which is built on the proven design of the Ortho Vision platform and maximizes efficiency with dependable full menu automation.

Additionally, attendees can also join an insightful session sponsored by QuidelOrtho on "How labs evolve when Sigma metrics are provided automatically." In addition to exploring how having assay Sigma metrics at the fingertips can transform lab management, attendees can learn what industry experts did with their data, the improvements they made, and how it impacted their operations. QuidelOrtho is also sponsoring the Society of Young Clinical Laboratorians (SYCL) events at ADLM 2024, demonstrating its commitment to supporting the next generation of clinical laboratorians and their professional development.


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.